Vaccine acceptance hinges on transparent communication

The COVID-19 pandemic has impacted our lives for well over a year. Many measures have been put in place to try to curb the spread of the virus. At individual level, people have adopted social distancing, hand washing and mask wearing. Schools, workplaces and businesses have changed their practices or closed their doors, and travel has been restricted. The hope that these measures can be eased rests on the successful rollout of COVID-19 vaccines.

Reaching vaccination targets has been difficult despite the triumphant development of new vaccine technologies. Developing, testing, authorising, manufacturing, allocating and disseminating vaccines is a Herculean task. The challenges are amplified as countries race against time to deal with the emergence of new virus variants and to reach herd immunity against the virus.

Lack of public confidence in and acceptance of COVID-19 vaccines could prove to be another major hurdle. Over a quarter (27%) of people living in Europe say that they are unlikely to take the COVID-19 vaccine. This hesitancy varies by country and by individual characteristics, including age, gender and educational level. Some of the starkest differences in vaccine hesitancy can be seen between people who use social media heavily and those who do not.

• Publication: Living, working and COVID-19 (Update April 2021): Mental health and trust decline across EU as pandemic enters another year

Vaccine refusal most common among heavy social media users

As Figure 1 shows, vaccine hesitancy is most common among people whose main source of news is social media or blogs, with 40% of this group saying they are unlikely to take a COVID-19 vaccine when one becomes available to them. In contrast, in the combined group of people who use traditional media (radio, television or the press) as their main source of news, under one-fifth (18%) say they are unlikely to accept a vaccine. Even when the impact of factors such as age, gender and health status is taken into account, the differences seen by main news source are statistically significant.

Figure 1: Vaccine hesitancy by main news source (%), EU27, February–March 2021

Note: The survey question was ‘How likely or unlikely is it that you will take the COVID-19 vaccine when it becomes available to you?’ The chart shows the percentages who answered ‘rather unlikely’ or ‘very unlikely’.

Source: Eurofound, Living, working and COVID-19 e-survey, round 3

COVID-19 vaccine refusal is also common among people who spend a lot of time on social media. As shown in Figure 2, vaccine hesitancy is greatest among people who spend more than three hours daily on social media: 30% of this group say they are unlikely to get vaccinated. Among people who spend less time on social media, 26% are vaccine hesitant. Again, differences remain statistically significant even when the impact of individual characteristics is accounted for.

Figure 2: Vaccine hesitancy by level of social media use (%), EU27, February–March 2021

Note: The survey question was: ‘How likely or unlikely is it that you will take the COVID-19 vaccine when it becomes available to you?’ The chart shows the percentages who answered ‘rather unlikely’ or ‘very unlikely’.

Source: Eurofound, Living, working and COVID-19 e-survey, round 3

These findings suggest how misinformation about vaccines and COVID-19 spread by social media platforms can shape people’s views about vaccines. They also underline the need for unbiased information so that people can make balanced decisions and disregard misinformation.

Peak in vaccination hesitancy coincides with AstraZeneca suspensions

Many EU countries suspended the rollout of the AstraZeneca COVID-19 vaccine in March 2021, following reports that a very small number of people had developed blood clots after receiving it. Many of the suspensions in Europe were announced on 11 March. Vaccine hesitancy was at its lowest in February but peaked in the week following the suspensions. Figure 3 focuses on the time around the suspensions. It shows that 34% of Europeans were vaccine hesitant in the week prior to 11 March, and this share rose to 38% in the week following the suspensions. Many countries lifted the suspensions after the European Medicines Agency (EMA) declared the vaccine safe on 18 March. In the week following EMA’s announcement, the hesitancy rate fell back to 32%. This volatility in attitudes shows the immediate impact that the availability of new information can have.

Figure 3: Vaccine hesitancy around the time of AstraZeneca suspensions (%), EU27, March 2021

Note: The survey question was: ‘How likely or unlikely is it that you will take the COVID-19 vaccine when it becomes available to you?’ The chart shows the percentages who answered ‘rather unlikely’ or ‘very unlikely’.

Source: Eurofound, Living, working and COVID-19 e-survey, round 3

Communicating clearly about vaccine safety

Even in the absence of misinformation, humans can be failed by their intuition when assessing risks and probabilities. It can be difficult to weigh up a very small risk of a serious adverse reaction to a vaccine against a small risk of developing a serious illness without a vaccination. In addition, people need to take into account the efficacy of the various vaccines, and the impact that their decision on immunisation will have on the risks faced by the wider population.

Complete transparency in communication builds public trust in vaccines. Providing clear and unbiased information about their safety and effectiveness is crucial for the success of vaccination programmes globally. But making information available does not go far enough. Getting unbiased information across to people who do not use mainstream media presents a challenge. On the upside, social media can be used to help defeat the virus. They can serve as forums in which policymakers and public health officials – and people in general – can provide information and engage with people to address their concerns, hopefully alleviating the hesitancy around vaccination.

Image © cherryandbees/Adobe Stock Photos